You are here

Home › U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old › U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old

U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old

Primary tabs

U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old

Thu, 2022-12-08 10:20 — mike kraft
U.S. FDA authorizes Moderna, Pfizer updated COVID boosters for 6 months old The U.S. Food and Drug Administration on Thursday authorized updated COVID-19 booster shots from Moderna and Pfizer and its partner BioNTech for children as young as 6 months of age. Reuters Reuters

...

The amended authorizations allow use of Moderna's bivalent shot in children 6 months through 5 years of age, while the Pfizer/BioNTech vaccine can be given to those aged 6 months through 4 years.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Demographics
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Policy
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
Health - US
RAC Vaccines and Vaccination Group
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks